VIRI
Price:
$0.155
Market Cap:
$206.50K
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and i...[Read more]
Industry
Biotechnology
IPO Date
2020-12-17
Stock Exchange
NASDAQ
Ticker
VIRI
According to Virios Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.27. This represents a change of -17.66% compared to the average of 8.83 of the last 4 quarters.
The mean historical Current Ratio of Virios Therapeutics, Inc. over the last ten years is 8.80. The current 7.27 Current Ratio has changed 8.17% with respect to the historical average. Over the past ten years (40 quarters), VIRI's Current Ratio was at its highest in in the June 2021 quarter at 26.22. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
8.80
Median
9.82
Minimum
0.03
Maximum
20.55
Discovering the peaks and valleys of Virios Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.44%
Maximum Annual Current Ratio = 20.55
Minimum Annual Increase = -39.80%
Minimum Annual Current Ratio = 0.03
Year | Current Ratio | Change |
---|---|---|
2023 | 11.62 | 44.81% |
2022 | 8.02 | -35.13% |
2021 | 12.37 | -39.80% |
2020 | 20.55 | 10.44% |
2019 | 0.19 | 509.69% |
The current Current Ratio of Virios Therapeutics, Inc. (VIRI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.67
5-year avg
10.55
10-year avg
8.80
Virios Therapeutics, Inc.’s Current Ratio is greater than SeaStar Medical Holding Corporation (0.24), greater than ZyVersa Therapeutics, Inc. (0.06), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than Revelation Biosciences, Inc. (1.10), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Zura Bio Limited (12.57), greater than Navidea Biopharmaceuticals, Inc. (0.56), greater than Immix Biopharma, Inc. (7.00), greater than CNS Pharmaceuticals, Inc. (0.31), greater than Altamira Therapeutics Ltd. (1.38), greater than Phio Pharmaceuticals Corp. (3.47), greater than TransCode Therapeutics, Inc. (1.25),
Company | Current Ratio | Market cap |
---|---|---|
0.24 | $13.22M | |
0.06 | $2.05M | |
1.65 | $2.95M | |
1.10 | $3.09M | |
1.03 | $1.88K | |
12.57 | $279.33M | |
0.56 | $100.08K | |
7.00 | $43.65M | |
0.31 | $3.62M | |
1.38 | $1.89M | |
3.47 | $2.69M | |
1.25 | $8.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virios Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Virios Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Virios Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Virios Therapeutics, Inc. (VIRI)?
What is the highest Current Ratio for Virios Therapeutics, Inc. (VIRI)?
What is the 3-year average Current Ratio for Virios Therapeutics, Inc. (VIRI)?
What is the 5-year average Current Ratio for Virios Therapeutics, Inc. (VIRI)?
How does the current Current Ratio for Virios Therapeutics, Inc. (VIRI) compare to its historical average?